W. Mark Watson's Net Worth
-$142 Thousand
Who is W. Mark Watson?
W. Mark Watson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, Inhibitor Therapeutics, Inc., Vaxart, Inc., TEKLA HEALTHCARE INVESTORS, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund, TEKLA LIFE SCIENCES INVESTORS, and SYKES ENTERPRISES INC.
SEC CIK
W. Mark Watson's CIK is 0001612372
Past Insider Trading and Trends
2018 was W. Mark Watson's most active year for acquiring shares with 11 total transactions. W. Mark Watson's most active month to acquire stocks was the month of July. 2017 was W. Mark Watson's most active year for disposing of shares, totalling 6 transactions. W. Mark Watson's most active month to dispose stocks was the month of February. 2022 saw W. Mark Watson paying a total of $329,021.60 for 232,011 shares, this is the most they've acquired in one year. In 2020 W. Mark Watson cashed out on 46,000 shares for a total of $145,640.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -90.66K |
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +9.26% | 7.68K |
—
|
—
| 90.66K |
Jan 27
| |||
Form 4
| +56.63% | 30K |
—
|
—
| 82.98K |
Aug 6
| |||
Form 4
| -19.70% | -13.00K |
$5.18 | -$67,340.00 | 52.98K |
Aug 17
| |||
Form 4
| +83.38% | 30K |
—
|
—
| 65.98K |
Aug 7
| |||
Form 4
| +220.10% | 24.74K |
—
|
—
| 35.98K |
Aug 13
| |||
Form 4
| +649.33% | 9.74K |
—
|
—
| 11.24K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inhibitor Therapeutics, Inc. (INTI) Snapshot price: $0.0382
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
| +5,436.00% | 543.6K |
$0.34 | -$121,176.00 | 553.6K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
∞
| 10K |
$0.13 | $1,300.00 | 10K |
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vaxart, Inc. (VXRT) Snapshot price: $1.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.22% | 7.38K |
—
|
—
| 42.13K |
Jun 26
| |||
Form 4
|
∞
| 20K |
$0.76 | $15,140.00 | 20K |
Dec 28
| |||
Form 4
|
∞
| 14.75K |
—
|
—
| 14.75K |
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TEKLA HEALTHCARE INVESTORS (HQH) Snapshot price: $17.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tekla Healthcare Opportunities Fund (THQ) Snapshot price: $18.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||